[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Specialty Enzymes Market 2023-2029

January 2023 | 76 pages | ID: GABBECDE3FF6EN
Gen Consulting Company

US$ 2,850.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Specialty enzymes are proteins that act as biocatalysts to accelerate reactions and produce the desired results in pharmaceuticals, biotechnology research and diagnostics reactions. In the pharmaceuticals industry, specialty enzymes play a major role in drug formulation and drug delivery. Such enzyme based pharmaceutical drug formulations are used for the treatment of chronic conditions such as cancer and AIDS. Specialty enzymes have been widely used in the biotechnology industry for research, particularly in the molecular biology. They are also used in genetic engineering techniques to cut, replicate and attach DNA as per the requirement. Specialty enzymes play a major role in the diagnosis of diseases such as cancer, cardiovascular diseases and lysosomal disorders. The global specialty enzymes market is expected to increase by USD 1.6 billion, at a compound annual growth rate (CAGR) of 7.2% from 2023 to 2029, according to the latest edition of the Global Specialty Enzymes Market Report.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global specialty enzymes market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, source, end user, and region. The global market for specialty enzymes can be segmented by product: carbohydrases, lipases, polymerases & nucleases, proteases, others. The carbohydrases segment was the largest contributor to the global specialty enzymes market in 2022. Specialty enzymes market is further segmented by source: animals, microorganisms, plants. According to the research, the microorganisms segment had the largest share in the global specialty enzymes market. Based on end user, the specialty enzymes market is segmented into: biotechnology, diagnostics, pharmaceuticals, others. The pharmaceuticals segment held the largest revenue share in 2022. On the basis of region, the specialty enzymes market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. Globally, North America made up the largest share of the specialty enzymes market.

Market Segmentation
By product: carbohydrases, lipases, polymerases & nucleases, proteases, others
By source: animals, microorganisms, plants
By end user: biotechnology, diagnostics, pharmaceuticals, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report also provides analysis of the key companies of the industry and their detailed company profiles including Advanced Enzyme Technologies Limited, Amano Enzymes Inc., Amicogen, Inc., Aumgene Biosciences Pvt. Ltd., BBI Solutions OEM Limited (Novo Holdings A/S), Biocatalysts Ltd., Codexis, Inc., F. Hoffmann-La Roche AG, International Flavors & Fragrances Inc. (DuPont Nutrition & Biosciences), Koninklijke DSM N.V., Meteoric Biopharmaceuticals Limited, Nagase & Co., Ltd., Novozymes A/S, Thermo Fisher Scientific, Inc., Zymtronix, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
To analyze and forecast the market size of the global specialty enzymes market.
To classify and forecast the global specialty enzymes market based on product, source, end user, region.
To identify drivers and challenges for the global specialty enzymes market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global specialty enzymes market.
To identify and analyze the profile of leading players operating in the global specialty enzymes market.

Why Choose This Report
Gain a reliable outlook of the global specialty enzymes market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints

PART 5. MARKET BREAKDOWN BY PRODUCT

Carbohydrases
Lipases
Polymerases & nucleases
Proteases
Others

PART 6. MARKET BREAKDOWN BY SOURCE

Animals
Microorganisms
Plants

PART 7. MARKET BREAKDOWN BY END USER

Biotechnology
Diagnostics
Pharmaceuticals
Others

PART 8. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 9. KEY COMPANIES

Advanced Enzyme Technologies Limited
Amano Enzymes Inc.
Amicogen, Inc.
Aumgene Biosciences Pvt. Ltd.
BBI Solutions OEM Limited (Novo Holdings A/S)
Biocatalysts Ltd.
Codexis, Inc.
F. Hoffmann-La Roche AG
International Flavors & Fragrances Inc. (DuPont Nutrition & Biosciences)
Koninklijke DSM N.V.
Meteoric Biopharmaceuticals Limited
Nagase & Co., Ltd.
Novozymes A/S
Thermo Fisher Scientific, Inc.
Zymtronix, Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER


More Publications